Sofinnova Ventures »

Pharvaris N V shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of Pharvaris N V (PHVS) shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in Pharvaris N V

Tip: Access up to 7 years of quarterly data

All positions including Pharvaris N V held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pharvaris N V by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2024-03-31 $14M 585k 23.11

More positions owned by Sofinnova Ventures

Natera (NTRA)
Vera Therapeutics Cl A (VERA)
Ascendis Pharma A/S Sponsored Adr (ASND)
Aerovate Therapeutics (AVTE)
Merck & Co (MRK)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Novo-Nordisk A S Adr (NVO)
Incyte Corporation (INCY)
Argenx SE Sponsored Adr (ARGX)
Intuitive Surgical (ISRG)
Dyne Therapeutics (DYN)
Inhibrx (INBX)
Elanco Animal Health (ELAN)
IDEXX Laboratories (IDXX)
AstraZeneca Sponsored Adr (AZN)

View all positions for Sofinnova Ventures

Top funds holding Pharvaris N V

General Atlantic
FMR
venBio Partners
Foresite Capital Management IV
Viking Global Investors
VR Adviser
Bain Capital Life Sciences Investors
Commodore Capital
Cormorant Asset Management
Novo A/S
Deerfield Management Company
EcoR1 Capital
5AM Venture Management
T. Rowe Price Associates
Rock Springs Capital Management

View all funds holding Pharvaris N V